Type 1 Diabetes (T1D)
Conditions
Keywords
Clinicians, Diabetes Technology
Brief summary
Youth with public insurance underutilize diabetes care, particularly diabetes technology which is associated with improvement in diabetes-specific outcomes. Thus, we urgently need studies to understand and increase diabetes technology utilization. This proposed research will (1) address the gap in knowledge of barriers and promoters in youth working with clinicians to identify and address factors associated with diabetes technology uptake and utilization.
Detailed description
As diabetes technologies have become more innovative and effective in the management of pediatric type 1 diabetes (T1D), research and usage has not engaged all youth living with T1D . Studies have consistently demonstrated lower rates of diabetes technology use in some youth. Although diabetes technology has the potential to improve in pediatric T1D outcomes. This proposal aims to build an evidence base for data-driven interventions designed to increase uptake and utilization of diabetes innovations by addressing barriers and supporting promoters of diabetes technology use. Focusing on clinicians, the overall objective of this proposal is to test a brief pilot intervention to increase provider recommendation of diabetes technology.
Interventions
BEHAVIORALIntervention to increase diabetes technology prescriptions
The design for this phase is a prospective pilot study. The intervention modules will be delivered weekly over a four-week period and will include pre- and post-intervention assessments of survey measurements. We will recruit 20 clinicians to participate in the delivery of the pilot intervention.
Sponsors
Stanford University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* age 18+ years, providers who care for youth with T1D for at least 50% of their clinical efforts, practicing in the United States, care for youth with public insurance, health care role of physicians, advanced practice providers, or certified diabetes care \& education specialists, and understand and willingness to follow study protocol.
Exclusion criteria
* significant cognitive impairment or medical or psychiatric condition that would interfere with participation in the study or lack of access to a smartphone or Wi-Fi via computer.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Interviews with you on your feedback on the intervention | Within 4 weeks upon intervention completion | The investigators will ask clincians questions in a 30-minute interview at the end of the four-week intervention. The investigators will evaluate feedback on ways the intervention could be more effective and what changes can be made to the intervention so that it is most effective. The investigators will ask clinicians if you they likely to change diabetes management after completing the intervention. |
| Survey questions on your feedback on the intervention | Within 4 weeks upon intervention completion | The investigators will ask clincians questions in a feedback survey at the end of the four-week intervention. These questions will be developed by the investigators and will ask ways the intervention could be more effective and what changes can be made to the intervention so that it is most effective. Example questions of what the investigators plan to ask in the survey include: - Was the study explained appropriately? - Was it logistically easy to participate in the study? How could it have improved? - What parts of the intervention were most helpful? - What parts could be cut? - What parts need to be added? - Are there certain types of people who are likely to do better with this intervention? |
| Tracking people who complete the study | Through study completion, an average of one year | The investigators will also keep track of who enrolled in the study and track how many people completed the intervention. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in diabetes technology usage | Within 4 weeks upon intervention completion | The investigators will ask you survey questions to understand clinician attitudes towards diabetes technology at the start and end of the study intervention. The investigators will use a validated survey measure called Diabetes Technology Attitudes Survey to assess this in addition to having conversations with clinicians to learn beliefs about diabetes technology. |
Outcome results
None listed